Esther E. Freeman

Freeman attended Milton Academy. As a child she was a competitive skier, and competed in the national championships at the age of twelve. By the age of fifteen Freeman was a member of the United States freestyle skiing team. After completing her doctorate Freeman returned to the United States, where she started a medical degree at Harvard Medical School, and soon after completed her specialist training in dermatology, at the Harvard Combined Dermatology Residency Training program. == Research and career ==

In 2011 Freeman began work with the World Health Organization, drafting guidelines on how to treat skin conditions that were associated with HIV in the developing world. For these efforts she was awarded the 2012 American Academy of Dermatology Members Making a Difference Award. In 2013 Freeman was appointed Director of Global Health Dermatology at the Massachusetts General Hospital. Here she continued to investigate HIV dermatology, with a particular focus on Kaposi's sarcoma. She serves on the leadership team of the International Alliance of Global Health Dermatology(GLODERM). Leadership during the COVID-19 pandemic and other outbreaks Freeman was a member of the American Academy of Dermatology task force on coronavirus disease. As part of this effort, she launched and helped to compile a registry of skin complaints of COVID-19 patients, identifying several new symptoms of COVID-19 that present in the skin. Freeman has since been involved in leadership for several other outbreaks, including the global Mpox outbreak in 2022, where she served on the WHO Clinical Guidelines Committee for Mpox and also compiled an international registry to more deeply characterize skin manifestations of the virus. Her work on outbreaks has been features in the Washington Post and NPR, among others. == Selected publications ==